Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today ...

Palisade Bio's PALI-2108 will be presented at Digestive Disease Week 2025, highlighting its potential in ulcerative colitis treatment. Palisade Bio's lead program PALI-2108 has been recognized, being ...